Noridian Prices Molecular Pathology Codes; Myriad Confirms Guidance for Fiscal 2013

Noridian Prices Molecular Pathology Codes; Myriad Confirms Guidance for Fiscal 2013

[at noodls] – March 1, 2013 SALT LAKE CITY, March 1, 2013 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Noridian Administrative Services LLC (Noridian), Medicare administrative … more

View todays social media effects on MYGN

View the latest stocks trending across Twitter. Click to view dashboard

See who Myriad is hiring next, click here to view

Share this post